- Zacks•21 hours ago
Tesaro (TSRO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
WALTHAM, Mass., Feb. 27, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the European Medicines Agency`s (EMA) Committee for Medicinal ...
WALTHAM, Mass., Feb. 27, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that the European Medicines Agency’ s Committee for Medicinal Products for Human Use has rendered ...
TSRO : Summary for TESARO, Inc. - Yahoo Finance
Tesaro, Inc. (TSRO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||184.93 x 100|
|Day's Range||183.75 - 188.45|
|52 Week Range||36.68 - 192.94|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-25.58|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|